Concord Biotech

Premium

Finance

28 August, 2023

Quadria Capital set to finish returning first fund, eyes new vehicle's first close

Quadria Capital, a healthcare-focused investor, has started distributing the gains from its 10-year -old first fund, along with the principal, ......

Premium

Healthcare

31 July, 2023

Quadria set to score another modest exit from India portfolio

Quadria Capital, a healthcare-focused private equity firm that recently committed around $158 million to GSK Velu-led eyecare chain Maxivision Eye Hospital, is looking at ......

Premium

General

28 July, 2023

Grapevine: Warburg eyes Brookfield's IT services bet; Concord, Manappuram arm gear up for IPOs

Private equity firm Warburg Pincus is in advanced talks to acquire an IT services business owned by Brookfield Asset Management, ......

Premium

Healthcare

10 September, 2021

Quadria Capital-backed Concord Biotech Pvt pivots to IPO, appoints banker

Quadria Capital-backed Concord Biotech has appointed a merchant bank as it moves a step forward towards raising capital via a ......

Premium

Healthcare

21 April, 2021

Quadria Capital preparing to exit biotech firm

India and Southeast Asia-focused Quadria Capital is preparing to exit a biotech portfolio firm as deals in the broader pharmaceuticals ......

Premium

Healthcare

06 August, 2018

Quadria Capital hits the road for new healthcare PE fund

Quadria Capital, a private equity firm which focuses on South- and Southeast Asia, has hit the road to raise its ......

Premium

Healthcare

22 September, 2016

Kedaara Capital scraps talks to buy into RG Stone; other PE firms in fray

Private equity firm Kedaara Capital has called off negotiations to acquire India Equity Partners’ (IEP) stake in RG Stone Urology ......